![Blindness / Anatomy / Vascular endothelial growth factor / PEDF / Diabetic retinopathy / Ranibizumab / Hypoxia-inducible factors / Angiogenesis / Bevacizumab / Angiology / Medicine / Biology Blindness / Anatomy / Vascular endothelial growth factor / PEDF / Diabetic retinopathy / Ranibizumab / Hypoxia-inducible factors / Angiogenesis / Bevacizumab / Angiology / Medicine / Biology](https://www.pdfsearch.io/img/798f13f6cbb9d7d1fd111a6157a69a3a.jpg) Date: 2015-05-22 15:03:31Blindness Anatomy Vascular endothelial growth factor PEDF Diabetic retinopathy Ranibizumab Hypoxia-inducible factors Angiogenesis Bevacizumab Angiology Medicine Biology | | PNAS PLUS Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy Savalan Babapoor-Farrokhrana,1, Kathleen Jeea,1, Brooks Puchnera, Syed JunaAdd to Reading ListSource URL: www.pnas.orgDownload Document from Source Website File Size: 1,25 MBShare Document on Facebook
|